UPDATE | June 29, 2023

Recognizing β-glucan impurities in biopharmaceuticals

  • MAIL

β-glucan process-related impurities can be introduced into biopharmaceutical products and can cause false-positive results. In this webinar, Soonbin Kwon, a senior scientist in MSAT, shares his insights on how to tackle this issue and which downstream processes can reduce β-glucan.

 

β-glucan process-related impurities can be introduced into biopharmaceutical products and can cause false-positive results. In this webinar, Soonbin Kwon, a senior scientist in MSAT, shares his insights on how to tackle this issue and which downstream processes can reduce β-glucan.

 

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required